temozolomide has been researched along with Deficiency, Mental in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide (TMZ) is a first-line chemotherapeutic agent for the treatment of glioma." | 8.12 | The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis. ( Duan, S; Gong, F; Li, Q; Wei, Y, 2022) |
| "Temozolomide (TMZ) is a first-line chemotherapeutic agent for the treatment of glioma." | 4.12 | The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis. ( Duan, S; Gong, F; Li, Q; Wei, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, Y | 1 |
| Duan, S | 1 |
| Gong, F | 1 |
| Li, Q | 1 |
1 other study available for temozolomide and Deficiency, Mental
| Article | Year |
|---|---|
The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; | 2022 |